34 related articles for article (PubMed ID: 11710547)
1. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
Wendelbo Ø; Nesthus I; Sjo M; Paulsen K; Ernst P; Bruserud Ø
Cancer Immunol Immunother; 2004 Aug; 53(8):740-7. PubMed ID: 15133630
[TBL] [Abstract][Full Text] [Related]
3. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.
Ersvaer E; Hampson P; Hatfield K; Ulvestad E; Wendelbo Ø; Lord JM; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jun; 56(6):913-25. PubMed ID: 17115221
[TBL] [Abstract][Full Text] [Related]
4. Effects of interferon gamma on native human acute myelogenous leukaemia cells.
Ersvaer E; Skavland J; Ulvestad E; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jan; 56(1):13-24. PubMed ID: 16612597
[TBL] [Abstract][Full Text] [Related]
5. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2000 Sep; 49(7):377-87. PubMed ID: 10999464
[TBL] [Abstract][Full Text] [Related]
6. T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC).
Olsnes AM; Motorin D; Ryningen A; Zaritskey AY; Bruserud Ø
Cancer Immunol Immunother; 2006 Jul; 55(7):830-40. PubMed ID: 16267679
[TBL] [Abstract][Full Text] [Related]
7. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon-gamma secretion.
Bruserud O; Mentzoni L; Foss B; Bergheim J; Berentsen S; Nesthus I
Cancer Immunol Immunother; 1996 Dec; 43(5):275-82. PubMed ID: 9024504
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of m6A regulator-mediated RNA methylation modification patterns and immune characteristics in Sjögren's syndrome.
Yin J; Fu J; Xu J; Chen C; Zhu H; Wang B; Yu C; Yang X; Cai R; Li M; Ji K; Wu W; Zhao Y; Zheng Z; Pu Y; Zheng L
Heliyon; 2024 Apr; 10(7):e28645. PubMed ID: 38596085
[TBL] [Abstract][Full Text] [Related]
9. HECT, UBA and WWE domain containing 1 represses cholesterol efflux during CD4
Yin J; Xu J; Chen C; Ma X; Zhu H; Xie L; Wang B; Shao Y; Zhao Y; Wei Y; Hu A; Zheng Z; Yu C; Fu J; Zheng L
Front Pharmacol; 2023; 14():1191692. PubMed ID: 37435494
[No Abstract] [Full Text] [Related]
10. CYP51-mediated cholesterol biosynthesis is required for the proliferation of CD4
Yin J; Fu J; Shao Y; Xu J; Li H; Chen C; Zhao Y; Zheng Z; Yu C; Zheng L; Wang B
Clin Exp Med; 2023 Sep; 23(5):1691-1711. PubMed ID: 36413274
[TBL] [Abstract][Full Text] [Related]
11. Miconazole Suppresses 27-Hydroxycholesterol-induced Inflammation by Regulating Activation of Monocytic Cells to a Proinflammatory Phenotype.
Kim BY; Son Y; Cho HR; Lee D; Eo SK; Kim K
Front Pharmacol; 2021; 12():691019. PubMed ID: 34744703
[TBL] [Abstract][Full Text] [Related]
12. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
Bruserud O; Ulvestad E
Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
[TBL] [Abstract][Full Text] [Related]
13. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
Bruserud O
Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
[TBL] [Abstract][Full Text] [Related]
14. Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells.
Bruserud O
Int J Immunopharmacol; 2000 Jan; 22(1):69-81. PubMed ID: 10684990
[TBL] [Abstract][Full Text] [Related]
15. [Drug-drug interaction of antifungal drugs].
Niwa T; Shiraga T; Takagi A
Yakugaku Zasshi; 2005 Oct; 125(10):795-805. PubMed ID: 16205037
[TBL] [Abstract][Full Text] [Related]
16. Antifungal agents. Part II. The azoles.
Terrell CL
Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
[TBL] [Abstract][Full Text] [Related]
17. Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia.
Bruserud O
Int Immunopharmacol; 2001 Nov; 1(12):2183-95. PubMed ID: 11710547
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
